Qingzao Side From The Sanjiao Dialectical Therapy Of Primary Sjogren's Syndrome Clinical Study

The use of Chinese medicine theory and the method of combining traditional Chinese and western medicine, in theory, clinical research both primary Sjogren's syndrome causes of disease, treatment of prescription system for a more in-depth study. According sanjiao function Syndrome Type, Qingsao developed for the treatment of the group to Mofulin for the control group, patients were observed in 43 cases (including 10 cases of the control group, the Group of 15 cases dry, dry Group 7 cases, the next Dryness 11 patients), the results show that: the control group, the total efficiency of 60% on a dry Group total efficiency 93.33%; dry in the total efficiency of 85.71%; dry under the total efficiency of 81.81 percent. The statistical processing, the control group and three groups of the total efficiency of the treatment group compared with statistical significance (P <0.05), three groups of the total efficiency of the control group; three groups between the treatment group compared with no significant efficiency difference (P> 0.05). Improving the clinical symptoms, signs, laboratory indicators in the treatment group were better than in the control group (P <0.01, P <0.05). Chinese medicine with modern medicine and pharmacology analysis, and its role through the mechanism may be anti-inflammatory, and improve the regulation of the immune function and microcirculation of blood rheology and other role in easing the symptoms of the purpose of preventing the progress of the disease.